作者:Kris S.T. Dias、Jaqueline P. Januário、Jéssica Lopes D’ Dego、Amanda L.T. Dias、Marcelo H. dos Santos、Ihosvany Camps、Luiz Felipe L. Coelho、Claudio Viegas
DOI:10.1016/j.bmc.2012.02.023
日期:2012.4
Six derivatives of guttiferone-A (LFQM-79, 80, 81, 82, 113 and 114) were synthesized and evaluated for their antimicrobial activity against the opportunistic or pathogenic fungi Candida albicans (ATCC 09548), Candida glabrata (ATCC 90030), Candida krusei (ATCC 6258), Candida parapsilosis (ATCC 69548), Candida tropicalis (ATCC 750), Cryptococcus neoformans (ATCC 90012), Trichophyton tonsurans, Microsporum
合成了六种古蒂胶酮A衍生物(LFQM-79、80、81、82、113和114)并评估了其对机会性或致病性真菌白色念珠菌(ATCC 09548),光滑念珠菌(ATCC 90030),念珠菌的抗菌活性克鲁斯(ATCC 6258),副念珠菌(ATCC 69548),热带念珠菌(ATCC 750),新隐球菌(ATCC 90012),扁毛癣菌,小孢子石膏以及针对机会性和致病性革兰氏阳性细菌金黄色葡萄球菌(ATCC 6)表皮葡萄球菌(ATCC 12228),蜡状芽孢杆菌(ATCC 11778)和革兰氏阴性大肠杆菌(ATCC 25922),铜绿假单胞菌(ATCC 9027),鼠伤寒沙门氏菌(ATCC 14028),变形杆菌(ATCC 25933)。将衍生物的抗微生物活性与Guttiferone-A进行了比较,结果显示它们比原始分子更有效,有时甚至比治疗药物中建立的标准药物强。目前的研究表明,Guttif